# Pacira BioSciences, Inc. (PCRX) MD&A by fiscal year

Verbatim Item 7 Management's Discussion and Analysis sections from Pacira BioSciences, Inc.'s 10-K filings, one page per fiscal year. Extracted from SEC filings with the same bounded parser for every year. Filer text, not grepcent analysis or investment advice.

- [FY 2025 MD&A](/company/PCRX/mda/fy2025/): filed 2026-02-26; accession 0001628280-26-012297 (https://www.sec.gov/Archives/edgar/data/1396814/000162828026012297/pcrx-20251231.htm); latest 10-K
- [FY 2024 MD&A](/company/PCRX/mda/fy2024/): filed 2025-02-27; accession 0001396814-25-000041 (https://www.sec.gov/Archives/edgar/data/1396814/000139681425000041/pcrx-20241231.htm)
- [FY 2023 MD&A](/company/PCRX/mda/fy2023/): filed 2024-02-29; accession 0001396814-24-000030 (https://www.sec.gov/Archives/edgar/data/1396814/000139681424000030/pcrx-20231231.htm)
- [FY 2022 MD&A](/company/PCRX/mda/fy2022/): filed 2023-02-28; accession 0001396814-23-000010 (https://www.sec.gov/Archives/edgar/data/1396814/000139681423000010/pcrx-20221231.htm)
- [FY 2021 MD&A](/company/PCRX/mda/fy2021/): filed 2022-02-28; accession 0001396814-22-000021 (https://www.sec.gov/Archives/edgar/data/1396814/000139681422000021/pcrx-20211231.htm)

Back to /company/PCRX/